Background There is a lack of atrial fibrillation (AF) prediction models tailored for individuals without prior ...

Background Serum potassium (sK) disorders are associated with worse outcomes in patients with heart failure with preserved ...

Background Aortic valve replacement (AVR) is considered one of the most potent disease-modifying procedures among patients ...

Background Cardiovascular-kidney-metabolic (CKM) syndrome plays a critical role in the pathogenesis of cardiovascular ...

Introduction Recent studies have highlighted the presence of right ventricular dysfunction (RVD) in a substantial proportion ...

Background Heart failure with preserved ejection fraction (HFpEF) poses global diagnostic and therapeutic challenges, with potential regional differences in clinical practice that remain underexplored ...

Background Women with acute myocardial infarction (AMI) experience higher mortality rates than men. This disparity is influenced by factors such as older age, greater comorbidity burden, atypical ...

Background Cardiac amyloidosis (CA) is the leading cause of mortality in systemic amyloidosis, highlighting the need for accurate risk assessment to guide patient management. While the diagnostic ...

Background The lack of effective therapies for heart failure with preserved ejection fraction (HFpEF) reflects an incomplete understanding of its pathogenesis.Design We analysed baseline risk factors ...